{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T07:54:59Z","timestamp":1791618899162,"version":"4.3.4"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Gout, primarily driven by hyperuricemia, is a prevalent inflammatory arthritis with kidney dysfunction being a significant risk factor. This study aims to comprehensively evaluate the global burden of gout attributable to kidney dysfunction from 1990 to 2021, highlighting differences across regions, genders, Socio-Demographic Index (SDI) levels, and age groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Using data from the Global Burden of Disease (GBD) 2021 study, we assessed the burden of gout due to kidney dysfunction using disability-adjusted life years (DALYs) and years lived with disability (YLDs). Kidney dysfunction was defined as an estimated glomerular filtration rate (eGFR) below 60 mL\/min\/1.73 m\u00b2 or an albumin-to-creatinine ratio (ACR) \u226530 mg\/g. The data were stratified by region, country, gender, age, and SDI quintiles. The annual percentage change (EAPC) was calculated to determine temporal trends.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>From 1990 to 2021, global DALYs and YLDs attributable to gout due to kidney dysfunction increased significantly, rising from 78,564.8 years (95% uncertainty interval 48,687.9\u2013118,061.9) to 200,033.3 years (125,245.0\u2013296,812.4), a 2.5-fold increase. The age-standardized DALY rate (ASDR) and age-standardized YLD rate both increased, from 2.1 per 100,000 population in 1990 to 2.4 per 100,000 in 2021. DALY and YLD rates were consistently higher in males than in females. High SDI countries, especially North America and Australasia, had the most significant rise in burden, whereas low SDI regions experienced a decline. The burden increased with age, particularly in those aged 60 and above.<\/jats:p><\/jats:sec><jats:sec><jats:title>Interpretation<\/jats:title><jats:p>This study underscores the substantial increase in the global burden of gout attributable to kidney dysfunction, particularly among the elderly, males, and populations in high SDI regions. The observed trends are driven by multiple factors, including lifestyle and dietary habits, diagnostic capacity, and demographic shifts. Future efforts should focus on improving surveillance and access to care in low-SDI regions to address potential underestimation of the burden. High-SDI regions should prioritize personalized health management strategies for the elderly, emphasizing early detection and intervention for gout and kidney dysfunction.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2025.1677340","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T04:12:35Z","timestamp":1761019955000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Trends in the global burden of gout attributable to kidney dysfunction, 1990-2021: a population-based analysis"],"prefix":"10.3389","volume":"16","author":[{"given":"Jiaxian","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingming","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00569-9","article-title":"Gout","volume":"397","author":"Dalbeth","year":"2021","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1001\/jama.2021.19770","article-title":"What is gout","volume":"326","author":"Yip","year":"2021","journal-title":"Jama Dec 28"},{"key":"B3","doi-asserted-by":"publisher","first-page":"o1754","DOI":"10.1136\/bmj.o1754","article-title":"Gout: diagnosis and management-summary of NICE guidance","volume":"378","author":"Neilson","year":"2022","journal-title":"Bmj"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/s2665-9913(24)00117-6","article-title":"Global, regional, and national burden of gout, 1990-2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021","volume":"6","year":"2024","journal-title":"Lancet Rheumatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003025","article-title":"Global, regional and national burdens of gout in the young population from 1990 to 2019: a population-based study","volume":"9","author":"Zhang","year":"2023","journal-title":"RMD Open"},{"key":"B6","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1186\/s12889-024-20799-w","article-title":"Global, regional, and national burden of gout in elderly 1990-2021: an analysis for the global burden of disease study 2021","volume":"24","author":"Li","year":"2024","journal-title":"BMC Public Health"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-020-0441-1","article-title":"Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors","volume":"16","author":"Dehlin","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1186\/s12891-024-08180-9","article-title":"Gout: global epidemiology, risk factors, comorbidities and complications: a narrative review","volume":"25","author":"Asghari","year":"2024","journal-title":"BMC Musculoskelet Disord"},{"key":"B9","doi-asserted-by":"publisher","first-page":"113377","DOI":"10.1016\/j.envres.2022.113377","article-title":"Environmental factors and risk of gout","volume":"212","author":"Wu","year":"2022","journal-title":"Environ Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.20110","article-title":"Serum urate and its association with gout flares","volume":"331","author":"Gaffo","year":"2024","journal-title":"Jama Feb 6"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/art.41571","article-title":"Prevalence, deaths, and disability-adjusted life years due to musculoskeletal disorders for 195 countries and territories 1990-2017","volume":"73","author":"Safiri","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"114890","DOI":"10.1016\/j.ejmech.2022.114890","article-title":"Recent advances in gout drugs","volume":"245","author":"Shi","year":"2023","journal-title":"Eur J Med Chem"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.3c01710","article-title":"Agents for the treatment of gout: current advances and future perspectives","volume":"66","author":"Zeng","year":"2023","journal-title":"J Med Chem"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1915833","article-title":"Effects of allopurinol on the progression of chronic kidney disease","volume":"382","author":"Badve","year":"2020","journal-title":"N Engl J Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/s41419-020-2673-z","article-title":"Delayed treatment with an autophagy inhibitor 3-MA alleviates the progression of hyperuricemic nephropathy","volume":"11","author":"Shi","year":"2020","journal-title":"Cell Death Dis"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5001641","article-title":"Low glomerular filtration in the population: prevalence, associated disorders, and awareness","volume":"70","author":"Cirillo","year":"2006","journal-title":"Kidney Int"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2022.11.016","article-title":"Uric acid and chronic kidney disease: still more to do","volume":"8","author":"Johnson","year":"2023","journal-title":"Kidney Int Rep"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2024.05.033","article-title":"Controversies and practical management of patients with gout and chronic kidney disease","volume":"106","author":"Johnson","year":"2024","journal-title":"Kidney Int"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2017.12.005","article-title":"Health-related quality of life in gout in primary care: Baseline findings from a cohort study","volume":"48","author":"Chandratre","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"395","year":"2020","journal-title":"Lancet"},{"key":"B21","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.jacc.2017.12.052","article-title":"Cardiovascular risks of probenecid versus allopurinol in older patients with gout","volume":"71","author":"Kim","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1093\/rheumatology\/keab539","article-title":"Improving outcomes for patients hospitalized with gout: a systematic review","volume":"61","author":"Russell","year":"2021","journal-title":"Rheumatol (Oxford)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.967769","article-title":"Role of microRNA alternation in the pathogenesis of gouty arthritis","volume":"13","author":"Luo","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1159\/000381291","article-title":"Gout after living kidney donation: correlations with demographic traits and renal complications","volume":"41","author":"Lam","year":"2015","journal-title":"Am J Nephrol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/dom.16165","article-title":"Risk acceleration by gout on major adverse cardiovascular events and all-cause death in patients with diabetes and chronic kidney disease","volume":"27","author":"Lee","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.1008598","article-title":"Trend dynamics of gout prevalence among the Chinese population, 1990-2019: A joinpoint and age-period-cohort analysis","volume":"10","author":"Zhu","year":"2022","journal-title":"Front Public Health"},{"key":"B27","doi-asserted-by":"publisher","first-page":"15575","DOI":"10.1038\/s41598-020-72505-6","article-title":"Urate in fingernail represents the deposition of urate burden in gout patients","volume":"10","author":"Chen","year":"2020","journal-title":"Sci Rep"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2433","article-title":"Dapagliflozin reduces uric acid concentration, an independent predictor of adverse outcomes in DAPA-HF","volume":"24","author":"McDowell","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22179221","article-title":"Molecular biological and clinical understanding of the pathophysiology and treatments of hyperuricemia and its association with metabolic syndrome, cardiovascular diseases and chronic kidney disease","volume":"22","author":"Yanai","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B30","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1001\/jamainternmed.2024.6212","article-title":"Target serum urate achievement and chronic kidney disease progression in patients with gout and kidney disease","volume":"185","author":"Wang","year":"2025","journal-title":"JAMA Intern Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"F542","DOI":"10.1152\/ajprenal.00287.2024","article-title":"Endothelial dysfunction in the aging kidney","volume":"328","author":"Borri","year":"2025","journal-title":"Am J Physiol Renal Physiol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"100438","DOI":"10.1016\/j.lanepe.2022.100438","article-title":"Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2\u00b74 million patients from 11 countries: The CaReMe CKD study","volume":"20","author":"Sundstr\u00f6m","year":"2022","journal-title":"Lancet Reg Health Eur"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2020010028","article-title":"The effects of high-protein diets on kidney health and longevity","volume":"31","author":"Ko","year":"2020","journal-title":"J Am Soc Nephrol Aug"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10408398.2025.2475238","article-title":"The human gut microbiota and uric acid metabolism: genes, metabolites, and diet","author":"Sun","year":"2025","journal-title":"Crit Rev Food Sci Nutr"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1080\/10408398.2020.1747046","article-title":"High-fat or high-sugar diets as trigger inflammation in the microbiota-gut-brain axis","volume":"61","author":"Jamar","year":"2021","journal-title":"Crit Rev Food Sci Nutr"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21124269","article-title":"Sex differences in urate handling","volume":"21","author":"Halperin Kuhns","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2020.12.002","article-title":"The shared genetic basis of hyperuricemia, gout, and kidney function","volume":"40","author":"Leask","year":"2020","journal-title":"Semin Nephrol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.2478\/jtim-2022-0031","article-title":"Prevalence and risk factors of hyperuricemia and gout: A cross-sectional survey from 31 provinces in mainland China","volume":"10","author":"Song","year":"2022","journal-title":"J Transl Int Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"514","DOI":"10.21037\/atm.2020.01.23","article-title":"The role of gender disparities in kidney injury","volume":"8","author":"Harris","year":"2020","journal-title":"Ann Transl Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/nqaa424","article-title":"Effects of dietary macronutrients on serum urate: results from the OmniHeart trial","volume":"113","author":"Belanger","year":"2021","journal-title":"Am J Clin Nutr"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3390\/cells11203269","article-title":"Key genes associated with pyroptosis in gout and construction of a miRNA-mRNA regulatory network","volume":"11","author":"Bai","year":"2022","journal-title":"Cells"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.5551\/jat.63907","article-title":"Risk factors for hyperuricemia or gout in men and women: the circulatory risk in communities study (CIRCS)","volume":"30","author":"Teramura","year":"2023","journal-title":"J Atheroscler Thromb"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.30700","article-title":"Consumption of total and specific alcoholic beverages and long-term risk of gout among men and women","volume":"7","author":"Lyu","year":"2024","journal-title":"JAMA Netw Open"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/nxaa324","article-title":"Nonalcoholic and alcoholic beverage intakes by adults across 5 upper-middle- and high-income countries","volume":"151","author":"Vanderlee","year":"2021","journal-title":"J Nutr"},{"key":"B45","doi-asserted-by":"publisher","first-page":"71","DOI":"10.5114\/aoms\/175469","article-title":"Global burden and epidemic trends of gout attributable to high body mass index from 1990 to 2019","volume":"20","author":"Jin","year":"2024","journal-title":"Arch Med Sci"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13937","article-title":"Global burden of gout in 1990-2019: A systematic analysis of the Global Burden of Disease study 2019","volume":"53","author":"Jeong","year":"2023","journal-title":"Eur J Clin Invest"},{"key":"B47","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1186\/1472-6963-14-477","article-title":"The implications of regional and national demographic projections for future GMS costs in Ireland through to 2026","volume":"14","author":"Conway","year":"2014","journal-title":"BMC Health Serv Res"},{"key":"B48","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1093\/ckj\/sfx002","article-title":"Urinary peptide-based classifier CKD273: towards clinical application in chronic kidney disease","volume":"10","author":"Pontillo","year":"2017","journal-title":"Clin Kidney J"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-019-04868-9","article-title":"Recent updates on worldwide gout epidemiology","volume":"39","author":"Mattiuzzi","year":"2020","journal-title":"Clin Rheumatol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"m1590","DOI":"10.1136\/bmj.m1590","article-title":"National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study","volume":"369","author":"Parisi","year":"2020","journal-title":"Bmj"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.19763","article-title":"Management of gout","volume":"326","author":"Anderson","year":"2021","journal-title":"Jama"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11030231","article-title":"The epidemiology and genetics of hyperuricemia and gout across major racial groups: A literature review and population genetics secondary database analysis","volume":"11","author":"Butler","year":"2021","journal-title":"J Pers Med"},{"key":"B53","doi-asserted-by":"publisher","first-page":"3310","DOI":"10.1038\/s41598-025-86090-z","article-title":"A comprehensive analysis of trends in the burden of gout in China and globally from 1990 to 2021","volume":"15","author":"Xie","year":"2025","journal-title":"Sci Rep"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17020456","article-title":"Prevalence of chronic kidney disease in cuttack district of odisha, India","volume":"17","author":"Mohanty","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"B55","doi-asserted-by":"publisher","first-page":"E612","DOI":"10.1503\/cmaj.221427","article-title":"An approach to treating older adults with chronic kidney disease","volume":"195","author":"Merchant","year":"2023","journal-title":"Cmaj"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfac199","article-title":"Ageing meets kidney disease","volume":"38","author":"Ortiz","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"B57","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12882-019-1274-5","article-title":"Gout is associated with a higher risk of chronic renal disease in older adults: a retrospective cohort study of U.S. Medicare population","volume":"20","author":"Singh","year":"2019","journal-title":"BMC Nephrol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1677340\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T04:12:36Z","timestamp":1761019956000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1677340\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":57,"alternative-id":["10.3389\/fendo.2025.1677340"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1677340","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"article-number":"1677340"}}